Benjamin Oakes

Benjamin Oakes is the founder of Scribe Therapeutics. Scribe Therapeutics has raised $120M in total funding. Latest round: Series A.

About Benjamin Oakes

Benjamin Oakes is the Co-founder, CEO, and President of Scribe Therapeutics, a gene-editing company he co-founded in October 2018. He previously worked in Jennifer Doudna's lab at UC Berkeley and participated in the Entrepreneurial in Genomics program.

Benjamin Oakes at a glance

More founders in Berkeley, California, United States (44)

Browse related founder lists (3)

Full founder directory · Investor directory · Company funding database · Fundraising library